Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
AEMPS · 239 medicines
AIFA · 217 medicines
Health Canada · 157 medicines
CBG-MEB · 103 medicines
SFDA · 35 medicines · Historical list
MS · 31 medicines · Historical list
HALMED · 21 medicines
TFDA · 19 medicines
ALIMS · 18 medicines
PHARMAC · 13 medicines
HSA · 10 medicines
EMA · 1 medicine
Every register, a page at a time. Strengths and packs are on each medicine’s page.
1,476 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Ethinyl Estradiol; EtonogestrelCombination | United States | 0.015MG/24HR; 0.12MG/24HR | ring | Marketed | Teva Pharms USA INC |
| Ethinyl Estradiol and NorelgestrominCombination | United States | 0.035MG/24HR; 0.15MG/24HR | film, extended release | Marketed | Zydus Pharms |
| Norgestimate; Ethinyl EstradiolCombination | United States | 0.215MG; 0.025MG, 0.215MG; 0.035MG, 0.25MG; 0.025MG … | tablet | Marketed | Glenmark Pharms LTD |
| Desogestrel and Ethinyl EstradiolCombination | United States | 0.15MG,N/A; 0.02MG,0.01MG, 0.15MG; 0.03MG, 0.1MG,0.125MG,0.15MG; 0.025MG,0.025MG,0.025MG | tablet | Marketed | DR Reddys Labs SA |
| Desogestrel; Ethinyl EstradiolCombination | United States | 0.125MG/0.025MG, 0.15MG/0.025MG | tablet | Marketed | DR Reddys Labs SA |
| Norgestimate and Ethinyl EstradiolCombination | United States | 0.025MG,0.025MG,0.025MG; 0.18MG,0.215MG,0.25MG, 0.035MG,0.035MG,0.035MG; 0.18MG,0.215MG,0.25MG, 0.035MG; 0.25MG | tablet | Marketed | Lupin |
| Drospirenone and Ethinyl EstradiolCombination | United States | 3MG; 0.03MG | tablet | Marketed | Lupin LTD |
| Drospirenone and Ethinyl EstradiolCombination | United States | 3MG; 0.02MG | tablet | Marketed | Hetero Labs |
| Levonorgestrel and Ethinyl EstradiolCombination | United States | 0.02MG; 0.1MG, 0.03MG,0.04MG,0.03MG; 0.05MG,0.075MG,0.125MG, 0.03MG; 0.15MG | tablet | Marketed | Xiromed |
| Levonorgestrel and Ethinyl EstradiolCombination | United States | 0.02MG; 0.09MG, 0.03MG,0.01MG; 0.15MG,N/A, 0.03MG; 0.15MG | tablet | Marketed | Glenmark Pharms LTD |
| Levonorgestrel and Ethinyl Estradiol and Ethinyl EstradiolCombination | United States | 0.02MG,0.15MG; 0.025MG,0.15MG, 0.02MG,0.1MG; 0.01MG,N/A, 0.03MG,0.01MG; 0.15MG,N/A | tablet | Marketed | DR Reddys Labs SA |
| Ethynodiol Diacetate and Ethinyl EstradiolCombination | United States | 0.035MG; 1MG, 0.05MG; 1MG | tablet | Marketed | Xiromed |
| Norethindrone Acetate and Ethinyl EstradiolCombination | United States | 0.02MG; 1MG, 0.03MG; 1.5MG | tablet | Marketed | Glenmark Pharms LTD |
| Norethindrone Acetate and Ethinyl EstradiolCombination | United States | 0.0025MG; 0.5MG, 0.005MG; 1MG | tablet | Marketed | Barr Labs INC |
| Norethindrone Acetate and Ethinyl EstradiolCombination | United States | 0.02MG,0.03MG,0.035MG; 1MG,1MG,1MG, 0.02MG; 1MG, 0.03MG; 1.5MG | tablet | Marketed | Xiromed |
| Norethindrone and Ethinyl EstradiolCombination | United States | 0.035MG,0.035MG,0.035MG; 0.5MG,0.75MG,1MG, 0.035MG; 0.4MG, 0.035MG; 0.5MG … | tablet | Marketed | Xiromed |
| Desogestrel and Ethinyl EstradiolCombination | United States | 0.15MG; 0.03MG | tablet | Not marketed | Duramed Pharms Barr |
| Ethinyl Estradiol; LevonorgestrelCombination | United States | 0.02MG,0.15MG; 0.025MG,0.15MG | tablet | Tentative approval | Mayne Pharma INC |
| Norethindrone and Ethinyl Estradiol (10/11)Combination | United States | 0.035MG,0.035MG; 0.5MG,1MG | tablet | Marketed | Watson Labs Teva |
| Norethindrone and Ethinyl Estradiol and Ferrous FumarateCombination | United States | 0.025MG; 0.8MG | tablet, chewable | Marketed | Xiromed |
| Norethindrone and Ethinyl Estradiol and Ferrous FumarateCombination | United States | 0.035MG; 0.4MG | tablet | Marketed | Naari Pte |
| Taro-Cyproterone/Ethinyl EstradiolCombination | Canada | 2 MG + 0.035 MG | Tablet | Marketed | Sun Pharma Canada INC |
| Teva-Cyproterone / Ethinyl EstradiolCombination | Canada | 2 MG + 0.035 MG | Tablet | Marketed | Teva Canada Limited |
| Levonorgestrel and Ethinyl Estradiol and Ferrous FumarateCombination | United States | 0.02MG; 0.1MG | tablet | Marketed | Xiromed |
| Ethinyl Estradiol and LevonorgestrelCombination | United States | 0.03MG,0.01MG; 0.15MG,N/A | tablet | Tentative approval | Novast Labs |
The same brand on several registers.
The companies holding its medicines, the most first.
Substances it shares a medicine with.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, ALIMS, Anvisa, CBG-MEB, EMA, FDA, HALMED, Health Canada, HSA, MS, PHARMAC, SFDA and TFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
